David K.R. Karaolis

3.2k citations

31 papers · 2.4k indexed · h-index 22

Co-authors: Peter R. Reeves James B. Kaper Ruiting Lan Judith A. Johnson Yoshihiro Hayakawa Mamoru Hyodo Edgar C. Boedeker Mohammed H. Rashid
Topics: Vibrio bacteria research studies (15 papers)Salmonella and Campylobacter epidemiology (8 papers)Aquaculture disease management and microbiota (7 papers)
Cited by: Endocrinology Immunology Molecular Medicine
Journals: Nature Proceedings of the National Academy of Sciences The Journal of Immunology
Partner nations: United States Japan Australia

In The Last Decade

David K.R. Karaolis

31 papers receiving 2.3k citations

Peers

Countries citing papers authored by David K.R. Karaolis

Since Specialization

Citations

This map shows the geographic impact of David K.R. Karaolis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David K.R. Karaolis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David K.R. Karaolis more than expected).

Fields of papers citing papers by David K.R. Karaolis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David K.R. Karaolis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David K.R. Karaolis. The network helps show where David K.R. Karaolis may publish in the future.

Co-authorship network of co-authors of David K.R. Karaolis

This figure shows the co-authorship network connecting the top 25 collaborators of David K.R. Karaolis. A scholar is included among the top collaborators of David K.R. Karaolis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David K.R. Karaolis. David K.R. Karaolis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	STING Ligand c-di-GMP Improves Cancer Vaccination against Metastatic Breast Cancer 2014 ·Cancer Immunology Research ·Dinesh Chandra,Wilber Quispe‐Tintaya,Arthee Jahangir,Denise Asafu‐Adjei,Ilyssa Ramos,Herman O. Sintim,Jie Zhou,Yoshihiro Hayakawa,David K.R. Karaolis,Claudia Gravekamp	201
2	Genome Sequence of the Attenuated Carbosap Vaccine Strain of Bacillus anthracis 2013 ·Genome Announcements ·(unknown),Brian Ondov,Diana Radune,(unknown),(unknown),(unknown),(unknown),(unknown),Thomas Blank,David K.R. Karaolis,Arthur M. Friedlander,James P. Burans,M. J. Rosovitz,Todd J. Treangen,Adam M. Phillippy,Nicholas H. Bergman	5
3	c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection 2009 ·Vaccine ·Dong‐Liang Hu,Kouji Narita,Mamoru Hyodo,Yoshihiro Hayakawa,Akio Nakane,David K.R. Karaolis	61
4	c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection 2008 ·Vaccine ·Abiodun D. Ogunniyi,James C. Paton,Alun C. Kirby,Jonathan A. McCullers,(unknown),Mamoru Hyodo,Yoshihiro Hayakawa,David K.R. Karaolis	65
5	Organic Synthesis, Chemical Properties, and Biological Activities of Cyclic bis(3'-5')Diguanylic Acid (c-di-GMP) and Its Analogs 2006 ·Journal of Synthetic Organic Chemistry Japan ·Mamoru Hyodo,Yoshihiro Hayakawa,David K.R. Karaolis	5
6	Chemical behavior of bis(3′–5′)diguanylic acid in aqueous solutions 2005 ·Nucleic Acids Symposium Series ·Mamoru Hyodo,(unknown),Yoshihiro Hayakawa,David K.R. Karaolis	9
7	3′,5′-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation 2005 ·Biochemical and Biophysical Research Communications ·David K.R. Karaolis,Kunrong Cheng,Michael Lipsky,Ahmed Elnabawi,Jennifer Catalano,Mamoru Hyodo,Yoshihiro Hayakawa,Jean‐Pierre Raufman	86
8	c-di-GMP (3′-5′-Cyclic Diguanylic Acid) Inhibits Staphylococcus aureus Cell-Cell Interactions and Biofilm Formation 2005 ·Antimicrobial Agents and Chemotherapy ·David K.R. Karaolis,Mohammed H. Rashid,Chythanya Rajanna,Wensheng Luo,Mamoru Hyodo,Yoshihiro Hayakawa	123
9	3′,5′-Cyclic Diguanylic Acid Reduces the Virulence of Biofilm-Forming Staphylococcus aureus Strains in a Mouse Model of Mastitis Infection 2005 ·Antimicrobial Agents and Chemotherapy ·Éric Brouillette,Mamoru Hyodo,Yoshihiro Hayakawa,David K.R. Karaolis,François Malouin	62
10	Genetic diversity and antibiotic resistance of clinical and environmental Vibrio cholerae suggests that many serogroups are reservoirs of resistance 2004 ·Epidemiology and Infection ·Leila Carvalho Campos,Viviane Zahner,Kátia Eliane Santos Avelar,(unknown),Daniel S. Pereira,(unknown),(unknown),C.A. Salles,David K.R. Karaolis	23
11	Identification of genes involved in the switch between the smooth and rugose phenotypes ofVibrio cholerae 2003 ·FEMS Microbiology Letters ·Mohammed H. Rashid,Chythanya Rajanna,Afsar Ali,David K.R. Karaolis	78
12	Role of exopolysaccharide, the rugose phenotype and VpsR in the pathogenesis of epidemic Vibrio cholerae 2003 ·FEMS Microbiology Letters ·Mohammed H. Rashid,Chythanya Rajanna,Dalin Zhang,Vincenzo Pasquale,Laurence S. Magder,Afsar Ali,Stefano Dumontet,David K.R. Karaolis	28
13	Characterization of a Vibrio cholerae phage isolated from the coastal water of Peru 2003 ·Environmental Microbiology ·(unknown),Irma Nelly Gutierrez Rivera,Erin K. Lipp,(unknown),David K.R. Karaolis,Anwar Huq,Rita R. Colwell	10
14	Analysis of theVibriopathogenicity island-encoded Mop protein suggests a pleiotropic role in the virulence of epidemicVibrio cholerae 2003 ·FEMS Microbiology Letters ·Dalin Zhang,Chythanya Rajanna,(unknown),David K.R. Karaolis	9
15	Prevalence of virulence-associated genes in clinical and environmentalVibrio choleraestrains isolated in Brazil between 1991 and 1999 2002 ·FEMS Microbiology Letters ·(unknown),(unknown),Irma Nelly Gutierrez Rivera,(unknown),David K.R. Karaolis,Leila Carvalho Campos	24
16	High-Frequency Rugose Exopolysaccharide Production by Vibrio cholerae 2002 ·Applied and Environmental Microbiology ·Afsar Ali,Mohammed H. Rashid,David K.R. Karaolis	58
17	The Vibrio Pathogenicity Island-Encoded Mop Protein Modulates the Pathogenesis and Reactogenicity of Epidemic Vibrio cholerae 2002 ·Infection and Immunity ·Dalin Zhang,(unknown),(unknown),David K.R. Karaolis	14
18	A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria 1999 ·Nature ·David K.R. Karaolis,Sita Somara,David R. Maneval,Judith A. Johnson,James B. Kaper	286
19	Cloning of the RDEC-1 Locus of Enterocyte Effacement (LEE) and Functional Analysis of the Phenotype on Hep-2 Cells 1997 ·Advances in experimental medicine and biology ·David K.R. Karaolis,Timothy K. McDaniel,James B. Kaper,Edgar C. Boedeker	20
20	The sixth and seventh cholera pandemics are due to independent clones separately derived from environmental, nontoxigenic, non-O1 Vibrio cholerae 1995 ·Journal of Bacteriology ·David K.R. Karaolis,Ruiting Lan,Peter R. Reeves	131

About David K.R. Karaolis

David K.R. Karaolis is a scholar working on Endocrinology, Molecular Medicine and Microbiology, having authored 31 papers that have together received 2.4k indexed citations. Recurring topics across this work include Vibrio bacteria research studies (15 papers), Salmonella and Campylobacter epidemiology (8 papers) and Aquaculture disease management and microbiota (7 papers). The work is most often cited by research in Endocrinology (1.2k citations), Immunology (1.1k citations) and Molecular Medicine (241 citations). David K.R. Karaolis has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Peter R. Reeves, James B. Kaper, Ruiting Lan, Judith A. Johnson, Yoshihiro Hayakawa, Mamoru Hyodo, Edgar C. Boedeker, Mohammed H. Rashid, Camella Bailey and Sita Somara. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact